Cargando…
The TDs/aptamer cTnI biosensors based on HCR and Au/Ti(3)C(2)-MXene amplification for screening serious patient in COVID-19 pandemic
The accurate assay of cardiac troponin I (cTnI) is very important for acute myocardial infarction (AMI), it also can be employed as an effective index for screening serious patients in COVID-19 pandemic before fatal heart injury to reduce the mortality. A ratiometric sensing strategy was proposed ba...
Autores principales: | Mi, Xiaona, Li, Hui, Tan, Rong, Feng, Bainian, Tu, Yifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258042/ https://www.ncbi.nlm.nih.gov/pubmed/34256261 http://dx.doi.org/10.1016/j.bios.2021.113482 |
Ejemplares similares
-
Chemiluminescence Biosensor for the Determination of Cardiac Troponin I (cTnI)
por: Tannenberg, Robert, et al.
Publicado: (2023) -
An ultrasensitive electrochemical sensing platform for the detection of cTnI based on aptamer recognition and signal amplification assisted by TdT
por: Lang, Mingjian, et al.
Publicado: (2020) -
Differential analysis of transient increases of serum cTnI in response to handling in rats
por: Mikaelian, Igor, et al.
Publicado: (2013) -
Biological Recognition-Based Electrochemical Aptasensor for Point-of-Care Detection of cTnI
por: Ma, Jianfeng, et al.
Publicado: (2023) -
Prediction of Outcomes Through Cystatin C and cTnI in Elderly Type 2 Myocardial Infarction Patients
por: Ma, Jinling, et al.
Publicado: (2023)